A Study of Two Fabrazyme (Agalsidase Beta) Dosing Regime

Project: Research project

Project Details

Description

A Study of Two Fabrazyme (Agalsidase Beta) Dosing Regimens in Treatment-naive, Male Pediatric Patients Without Severe Symptoms (FIELD)
StatusFinished
Effective start/end date1/1/1312/31/17

Funding

  • GENZYME CORPORATION